-Reuters
Morgan Stanley Downgrades NCR to Equal-Weight, Lowers Price Target to $27
Morgan Stanley analyst Erik Woodring downgrades NCR (NYSE:NCR) from Overweight to Equal-Weight and lowers the price target from $38 to $27.
Related Posts
Syra Health Announces Partnership For A Federal Contract Valued At $75B
Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions,
Coinbase Warns SEC: Don’t Mess With Crypto’s Big Dog
Coinbase Global Inc. (NASDAQ: COIN) is taking steps to prevent the SEC from filing a lawsuit against the firm, emphasizing the challenges the agency might face in such a legal battle.
Celebrating 4/20 With Purpose: Wana Brands Surpasses $4.2M In Charitable Donations Since 2021
Discover how Wana Brands transforms 4/20 with over $4.2M donated to charities, championing community, sustainability, and global betterment.